Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study
Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands. dirk.deruysscher@maastro.nl